Neurodevelopmental Outcomes in Infants with Retinopathy of Prematurity and Bevacizumab Treatment

PURPOSE: The current study aims to investigate the neurodevelopment of premature infants after intravitreal injections of bevacizumab (IVB) for the treatment of retinopathy of prematurity (ROP) up to the age of 2 years. METHODS: The study design was retrospective observational case series conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Lien, Reyin, Yu, Mu-Hsien, Hsu, Kuang-Hung, Liao, Pei-Ju, Chen, Yen-Po, Lai, Chi-Chun, Wu, Wei-Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729687/
https://www.ncbi.nlm.nih.gov/pubmed/26815000
http://dx.doi.org/10.1371/journal.pone.0148019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729687/
https://www.ncbi.nlm.nih.gov/pubmed/26815000
http://dx.doi.org/10.1371/journal.pone.0148019

Ejemplares similares